| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Olive Oil | 1 | 2019 | 46 | 0.76 | Why? |
| Neomycin | 1 | 2018 | 21 | 0.76 | Why? |
| Heart Bypass, Right | 1 | 2017 | 2 | 0.74 | Why? |
| Dysentery, Bacillary | 1 | 2018 | 38 | 0.73 | Why? |
| Ampicillin | 1 | 2018 | 73 | 0.72 | Why? |
| Conjunctivitis, Allergic | 1 | 2018 | 94 | 0.67 | Why? |
| Salmonella | 1 | 2017 | 58 | 0.65 | Why? |
| Orthopedics | 2 | 2018 | 1279 | 0.62 | Why? |
| Salmonella Infections | 1 | 2017 | 82 | 0.61 | Why? |
| Fibromyalgia | 1 | 2018 | 174 | 0.61 | Why? |
| Career Choice | 2 | 2018 | 498 | 0.57 | Why? |
| Randomized Controlled Trials as Topic | 21 | 2021 | 10649 | 0.56 | Why? |
| Rheumatologists | 1 | 2018 | 346 | 0.55 | Why? |
| Diet, Mediterranean | 1 | 2019 | 351 | 0.54 | Why? |
| Rhinitis, Allergic | 2 | 2018 | 704 | 0.53 | Why? |
| Desensitization, Immunologic | 1 | 2018 | 574 | 0.49 | Why? |
| Pediatrics | 2 | 2018 | 2969 | 0.45 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.45 | Why? |
| Students, Medical | 3 | 2018 | 4032 | 0.40 | Why? |
| Evidence-Based Medicine | 6 | 2020 | 3228 | 0.38 | Why? |
| Adrenal Cortex Hormones | 3 | 2020 | 6537 | 0.35 | Why? |
| Rheumatology | 1 | 2018 | 1213 | 0.35 | Why? |
| Aerosols | 2 | 2021 | 5393 | 0.34 | Why? |
| Motivation | 1 | 2017 | 1640 | 0.32 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.32 | Why? |
| Anti-Infective Agents | 2 | 2021 | 1766 | 0.31 | Why? |
| Cancer Pain | 2 | 2017 | 91 | 0.30 | Why? |
| Anti-Allergic Agents | 2 | 2018 | 167 | 0.30 | Why? |
| Postoperative Hemorrhage | 2 | 2017 | 183 | 0.29 | Why? |
| Patient Outcome Assessment | 3 | 2018 | 707 | 0.28 | Why? |
| Myocardial Infarction | 1 | 2019 | 3361 | 0.24 | Why? |
| Asthma | 2 | 2018 | 4383 | 0.24 | Why? |
| History, 20th Century | 2 | 2018 | 1282 | 0.22 | Why? |
| Pain Management | 3 | 2018 | 854 | 0.21 | Why? |
| Analgesics, Opioid | 3 | 2018 | 1070 | 0.21 | Why? |
| Carrageenan | 1 | 2021 | 123 | 0.20 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.20 | Why? |
| Chronic Pain | 2 | 2018 | 736 | 0.20 | Why? |
| Cost-Benefit Analysis | 3 | 2018 | 2259 | 0.20 | Why? |
| Postoperative Complications | 5 | 2019 | 5861 | 0.19 | Why? |
| Research Design | 4 | 2021 | 5830 | 0.19 | Why? |
| Administration, Sublingual | 1 | 2018 | 41 | 0.19 | Why? |
| Shoulder Pain | 1 | 2019 | 36 | 0.19 | Why? |
| Deoxyguanosine | 1 | 2018 | 19 | 0.19 | Why? |
| Subject Headings | 1 | 2018 | 2 | 0.19 | Why? |
| Cannabinoids | 2 | 2018 | 134 | 0.19 | Why? |
| Iron, Dietary | 1 | 2018 | 13 | 0.19 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.19 | Why? |
| Blalock-Taussig Procedure | 1 | 2017 | 4 | 0.18 | Why? |
| Hepatomegaly | 1 | 2017 | 34 | 0.18 | Why? |
| Decompression, Surgical | 1 | 2019 | 114 | 0.18 | Why? |
| Postoperative Nausea and Vomiting | 1 | 2017 | 30 | 0.17 | Why? |
| Comparative Effectiveness Research | 1 | 2018 | 178 | 0.17 | Why? |
| Anesthesia, Intravenous | 1 | 2017 | 37 | 0.17 | Why? |
| Infant Formula | 1 | 2018 | 64 | 0.17 | Why? |
| Lost to Follow-Up | 1 | 2017 | 79 | 0.17 | Why? |
| Anesthesia, Inhalation | 1 | 2017 | 49 | 0.17 | Why? |
| Multimedia | 1 | 2016 | 14 | 0.17 | Why? |
| Ascites | 1 | 2017 | 65 | 0.17 | Why? |
| Therapy, Computer-Assisted | 1 | 2017 | 39 | 0.17 | Why? |
| Paraplegia | 1 | 2017 | 38 | 0.17 | Why? |
| Publishing | 2 | 2018 | 990 | 0.17 | Why? |
| Ezetimibe | 1 | 2017 | 50 | 0.17 | Why? |
| Patient Dropouts | 1 | 2017 | 96 | 0.16 | Why? |
| Punctures | 1 | 2017 | 89 | 0.16 | Why? |
| Health Planning Guidelines | 1 | 2017 | 133 | 0.16 | Why? |
| Histamine H1 Antagonists | 1 | 2017 | 79 | 0.16 | Why? |
| Patient Education as Topic | 2 | 2017 | 1476 | 0.16 | Why? |
| Milk | 1 | 2018 | 158 | 0.16 | Why? |
| Fracture Healing | 1 | 2016 | 37 | 0.16 | Why? |
| Cardiovascular Diseases | 2 | 2019 | 11497 | 0.16 | Why? |
| Financing, Organized | 1 | 2018 | 137 | 0.16 | Why? |
| Anesthesia, Epidural | 1 | 2017 | 92 | 0.16 | Why? |
| Injections, Subcutaneous | 1 | 2018 | 647 | 0.16 | Why? |
| Muscle Spasticity | 1 | 2017 | 117 | 0.16 | Why? |
| Mandatory Reporting | 1 | 2017 | 140 | 0.15 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.15 | Why? |
| Drugs, Investigational | 1 | 2018 | 198 | 0.15 | Why? |
| Death | 1 | 2019 | 334 | 0.15 | Why? |
| Postpartum Hemorrhage | 1 | 2017 | 144 | 0.15 | Why? |
| Stroke | 1 | 2019 | 8839 | 0.15 | Why? |
| Bias | 2 | 2018 | 1109 | 0.14 | Why? |
| Enteral Nutrition | 1 | 2018 | 320 | 0.14 | Why? |
| Data Accuracy | 2 | 2018 | 715 | 0.14 | Why? |
| Multicenter Studies as Topic | 2 | 2019 | 2437 | 0.14 | Why? |
| Humans | 57 | 2021 | 930598 | 0.14 | Why? |
| Venous Thromboembolism | 3 | 2018 | 4273 | 0.14 | Why? |
| United States Food and Drug Administration | 2 | 2019 | 1276 | 0.14 | Why? |
| Cats | 2 | 2018 | 1890 | 0.14 | Why? |
| Cannula | 1 | 2020 | 750 | 0.14 | Why? |
| Specialization | 1 | 2018 | 432 | 0.14 | Why? |
| Electric Stimulation Therapy | 1 | 2016 | 151 | 0.14 | Why? |
| Review Literature as Topic | 1 | 2018 | 387 | 0.14 | Why? |
| Graft Survival | 1 | 2017 | 587 | 0.13 | Why? |
| Administration, Oral | 2 | 2018 | 2340 | 0.13 | Why? |
| Anesthetics, Local | 1 | 2017 | 205 | 0.13 | Why? |
| Bone Neoplasms | 1 | 2017 | 287 | 0.13 | Why? |
| Publications | 1 | 2019 | 463 | 0.13 | Why? |
| Plant Preparations | 1 | 2017 | 276 | 0.13 | Why? |
| Network Meta-Analysis | 3 | 2020 | 426 | 0.13 | Why? |
| Disclosure | 1 | 2017 | 423 | 0.12 | Why? |
| Sex Workers | 1 | 2017 | 348 | 0.12 | Why? |
| Professional Practice | 1 | 2017 | 322 | 0.12 | Why? |
| Antidepressive Agents | 1 | 2018 | 509 | 0.12 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.12 | Why? |
| Drug Approval | 2 | 2019 | 1325 | 0.12 | Why? |
| Tobacco Smoking | 1 | 2017 | 349 | 0.12 | Why? |
| Urologic Neoplasms | 1 | 2017 | 348 | 0.12 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.12 | Why? |
| Financing, Government | 1 | 2017 | 434 | 0.12 | Why? |
| Information Storage and Retrieval | 1 | 2018 | 644 | 0.12 | Why? |
| Allergens | 1 | 2018 | 728 | 0.12 | Why? |
| Caregivers | 2 | 2017 | 3112 | 0.11 | Why? |
| Cat Diseases | 1 | 2018 | 539 | 0.11 | Why? |
| Ivermectin | 1 | 2021 | 973 | 0.11 | Why? |
| Physical Examination | 1 | 2017 | 755 | 0.11 | Why? |
| Dog Diseases | 1 | 2018 | 745 | 0.11 | Why? |
| Coronary Artery Bypass | 1 | 2017 | 629 | 0.11 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.11 | Why? |
| Fractures, Bone | 1 | 2016 | 487 | 0.10 | Why? |
| Pulmonary Artery | 1 | 2017 | 803 | 0.10 | Why? |
| Independent Living | 1 | 2017 | 842 | 0.10 | Why? |
| Search Engine | 1 | 2018 | 628 | 0.10 | Why? |
| Clinical Trials as Topic | 2 | 2020 | 7330 | 0.10 | Why? |
| Child Abuse | 1 | 2017 | 504 | 0.10 | Why? |
| Disease Management | 2 | 2018 | 6841 | 0.10 | Why? |
| Hepatitis B | 1 | 2017 | 888 | 0.10 | Why? |
| Electronic Nicotine Delivery Systems | 1 | 2017 | 561 | 0.09 | Why? |
| Urologic Diseases | 1 | 2017 | 860 | 0.09 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.09 | Why? |
| Anti-Retroviral Agents | 1 | 2017 | 1099 | 0.09 | Why? |
| Homosexuality, Male | 1 | 2017 | 1158 | 0.09 | Why? |
| Social Stigma | 1 | 2017 | 1049 | 0.09 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.09 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.09 | Why? |
| Heart Defects, Congenital | 1 | 2017 | 933 | 0.09 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.09 | Why? |
| Infant | 4 | 2018 | 30274 | 0.09 | Why? |
| MEDLINE | 2 | 2018 | 76 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Depressive Disorder | 1 | 2018 | 1236 | 0.08 | Why? |
| Clinical Decision-Making | 2 | 2018 | 3755 | 0.08 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Point-of-Care Systems | 2 | 2018 | 2955 | 0.08 | Why? |
| Anesthesiology | 1 | 2018 | 1163 | 0.08 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.08 | Why? |
| Frail Elderly | 1 | 2017 | 1427 | 0.08 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.08 | Why? |
| Databases, Factual | 2 | 2020 | 6248 | 0.08 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.08 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| Treatment Outcome | 8 | 2021 | 51732 | 0.08 | Why? |
| Graft Rejection | 1 | 2017 | 1766 | 0.08 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.08 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.08 | Why? |
| Antineoplastic Agents | 2 | 2019 | 3550 | 0.08 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.07 | Why? |
| Pain Measurement | 2 | 2018 | 533 | 0.07 | Why? |
| Qualitative Research | 1 | 2017 | 4337 | 0.07 | Why? |
| Patient Readmission | 1 | 2014 | 1543 | 0.07 | Why? |
| Canada | 1 | 2018 | 6018 | 0.07 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.07 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.07 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.07 | Why? |
| Thromboembolism | 1 | 2017 | 2101 | 0.07 | Why? |
| Quality of Life | 4 | 2019 | 9820 | 0.07 | Why? |
| Life Style | 1 | 2017 | 2708 | 0.07 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.07 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
| Stress, Psychological | 2 | 2017 | 10231 | 0.07 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.06 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.06 | Why? |
| Periodicals as Topic | 1 | 2016 | 1492 | 0.06 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.06 | Why? |
| Severity of Illness Index | 4 | 2020 | 48226 | 0.06 | Why? |
| Infant, Newborn | 3 | 2018 | 23105 | 0.06 | Why? |
| Occupational Diseases | 1 | 2017 | 2787 | 0.06 | Why? |
| Organ Transplantation | 1 | 2017 | 2616 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.06 | Why? |
| Patient Preference | 2 | 2018 | 750 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2017 | 43792 | 0.06 | Why? |
| Multiple Sclerosis | 1 | 2017 | 2600 | 0.06 | Why? |
| Child | 4 | 2018 | 70012 | 0.05 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Neoplasms | 2 | 2019 | 17251 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.05 | Why? |
| Switzerland | 2 | 2018 | 2738 | 0.05 | Why? |
| Antidepressive Agents, Tricyclic | 1 | 2018 | 29 | 0.05 | Why? |
| Drug Combinations | 2 | 2020 | 3852 | 0.05 | Why? |
| Epidemiologic Studies | 1 | 2021 | 554 | 0.05 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.05 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.05 | Why? |
| Patient Discharge | 1 | 2014 | 5696 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.04 | Why? |
| Urologic Surgical Procedures | 2 | 2017 | 996 | 0.04 | Why? |
| Euthanasia | 1 | 2018 | 21 | 0.04 | Why? |
| Methyl Ethers | 1 | 2017 | 22 | 0.04 | Why? |
| Coronary Artery Bypass, Off-Pump | 1 | 2017 | 27 | 0.04 | Why? |
| Planning Techniques | 1 | 2017 | 97 | 0.04 | Why? |
| Zidovudine | 1 | 2017 | 63 | 0.04 | Why? |
| Cytochrome P-450 Enzyme System | 1 | 2018 | 144 | 0.04 | Why? |
| Infant Nutritional Physiological Phenomena | 1 | 2018 | 75 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
| Twins | 1 | 2018 | 115 | 0.04 | Why? |
| Injections, Epidural | 1 | 2017 | 45 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Nicotinic Agonists | 1 | 2017 | 56 | 0.04 | Why? |
| Reproducibility of Results | 3 | 2019 | 11304 | 0.04 | Why? |
| International Normalized Ratio | 1 | 2018 | 300 | 0.04 | Why? |
| Emtricitabine | 1 | 2017 | 202 | 0.04 | Why? |
| Anesthetics, Intravenous | 1 | 2017 | 98 | 0.04 | Why? |
| Animals | 4 | 2018 | 78931 | 0.04 | Why? |
| Anesthetics, Inhalation | 1 | 2017 | 82 | 0.04 | Why? |
| Chemoprevention | 1 | 2021 | 585 | 0.04 | Why? |
| Vitamin K | 1 | 2018 | 263 | 0.04 | Why? |
| Internship and Residency | 1 | 2017 | 4987 | 0.04 | Why? |
| Lamivudine | 1 | 2017 | 210 | 0.04 | Why? |
| Lidocaine | 1 | 2017 | 94 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.04 | Why? |
| Intensive Care, Neonatal | 1 | 2018 | 284 | 0.04 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.04 | Why? |
| Dizziness | 1 | 2017 | 275 | 0.04 | Why? |
| Sample Size | 1 | 2017 | 518 | 0.04 | Why? |
| Propofol | 1 | 2017 | 172 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.04 | Why? |
| Hospitals | 1 | 2014 | 11793 | 0.03 | Why? |
| Anticholesteremic Agents | 1 | 2017 | 186 | 0.03 | Why? |
| Female | 11 | 2020 | 380317 | 0.03 | Why? |
| Lopinavir | 2 | 2020 | 4308 | 0.03 | Why? |
| Nausea | 1 | 2017 | 457 | 0.03 | Why? |
| Diagnosis-Related Groups | 1 | 2014 | 167 | 0.03 | Why? |
| Ritonavir | 2 | 2020 | 4212 | 0.03 | Why? |
| Male | 10 | 2020 | 367725 | 0.03 | Why? |
| Tenofovir | 1 | 2017 | 449 | 0.03 | Why? |
| Behavior Therapy | 1 | 2017 | 235 | 0.03 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Academies and Institutes | 1 | 2017 | 539 | 0.03 | Why? |
| Vomiting | 1 | 2018 | 722 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
| Pain, Postoperative | 1 | 2017 | 289 | 0.03 | Why? |
| Developed Countries | 1 | 2017 | 500 | 0.03 | Why? |
| Cattle | 1 | 2018 | 1336 | 0.03 | Why? |
| Anticonvulsants | 1 | 2018 | 634 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Spinal Cord Injuries | 1 | 2017 | 270 | 0.03 | Why? |
| Patient Selection | 2 | 2017 | 4560 | 0.03 | Why? |
| United States | 4 | 2020 | 46150 | 0.03 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.03 | Why? |
| Anesthesiologists | 1 | 2017 | 614 | 0.03 | Why? |
| Ontario | 1 | 2017 | 1966 | 0.03 | Why? |
| Phytotherapy | 1 | 2017 | 743 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Uncertainty | 1 | 2021 | 1888 | 0.02 | Why? |
| Exercise Therapy | 1 | 2019 | 976 | 0.02 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.02 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2018 | 1731 | 0.02 | Why? |
| Milk, Human | 1 | 2018 | 956 | 0.02 | Why? |
| Risk Assessment | 3 | 2018 | 25439 | 0.02 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.02 | Why? |
| Learning | 1 | 2017 | 1181 | 0.02 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.02 | Why? |
| Activities of Daily Living | 1 | 2017 | 1530 | 0.02 | Why? |
| Geriatric Assessment | 1 | 2017 | 1372 | 0.02 | Why? |
| Delivery of Health Care | 1 | 2014 | 15909 | 0.02 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.02 | Why? |
| Guideline Adherence | 1 | 2020 | 2309 | 0.02 | Why? |
| Research Personnel | 1 | 2017 | 1037 | 0.02 | Why? |
| Heparin | 1 | 2018 | 2600 | 0.02 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.02 | Why? |
| Health Education | 1 | 2016 | 1539 | 0.02 | Why? |
| Workplace | 1 | 2017 | 2075 | 0.02 | Why? |
| Pregnancy | 2 | 2017 | 23879 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| China | 2 | 2020 | 50654 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Education, Medical, Graduate | 1 | 2017 | 2082 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.02 | Why? |
| Odds Ratio | 1 | 2014 | 5861 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.01 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.01 | Why? |
| Transplant Recipients | 1 | 2017 | 4982 | 0.01 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.01 | Why? |
| Middle Aged | 4 | 2020 | 270681 | 0.01 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2017 | 5164 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Aged | 3 | 2020 | 215776 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.01 | Why? |
| Depression | 1 | 2017 | 14116 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |